Latest Sales Growth News

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

Nick Scali Limited has upgraded its first half FY26 revenue and profit guidance, citing stronger than expected sales growth in Australia and New Zealand.

CONNEQT Health has raised $3.1 million through an institutional placement to fuel growth of its Pulse vascular health device, supported by both new and existing investors including its largest shareholder.

Elixinol Wellness has amended acquisition terms for The Healthy Chef after its US distributor exited, reducing earnout payments and refocusing growth efforts on Australia.

OMG Group has achieved over $3 million in sales for the first half of FY2026, marking its strongest half-year performance since new management took charge. The company is poised for further growth with upcoming marketing campaigns and retail partnerships.

Cedar Woods Properties has raised its FY26 net profit guidance to at least 20% growth, driven by strong sales and faster project delivery, setting the stage for record earnings and higher dividends.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

CONNEQT Health’s Pulse arterial health monitor sales have outpaced expectations with over 200% growth in the December quarter, driven by efficient marketing and early subscription uptake.

Contact Energy's November 2025 report reveals increased electricity and gas sales alongside higher generation costs, while significant renewable projects advance on schedule.

Oliver’s Real Food reported a notable 6.5% rise in same-store sales for November 2025 alongside a 22% reduction in expenses, signaling improved operational efficiency. Despite a slight revenue dip year-to-date, the company’s profitability metrics show encouraging signs as it heads into the holiday season.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Myer Holdings Limited reported steady FY25 financial results with $4.076 billion in sales and outlined ambitious growth strategies at its Annual General Meeting, alongside key director re-elections and executive incentives.